Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 122 | 2024 | 6172 | 5.250 |
Why?
|
Polymorphism, Single Nucleotide | 91 | 2024 | 15773 | 1.840 |
Why?
|
Genetic Predisposition to Disease | 73 | 2024 | 17767 | 1.540 |
Why?
|
Genome-Wide Association Study | 49 | 2024 | 12604 | 1.430 |
Why?
|
Immunoglobulin E | 14 | 2018 | 1484 | 1.250 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 21 | 2023 | 3217 | 0.970 |
Why?
|
Quantitative Trait Loci | 14 | 2018 | 2100 | 0.910 |
Why?
|
Nonmuscle Myosin Type IIB | 1 | 2022 | 21 | 0.840 |
Why?
|
Gene Expression Profiling | 21 | 2020 | 9404 | 0.830 |
Why?
|
Elastin | 4 | 2017 | 300 | 0.830 |
Why?
|
Gene Expression Regulation | 23 | 2024 | 11893 | 0.730 |
Why?
|
Pulmonary Fibrosis | 2 | 2023 | 506 | 0.710 |
Why?
|
Phenotype | 40 | 2020 | 16533 | 0.680 |
Why?
|
Lung Diseases, Interstitial | 7 | 2023 | 910 | 0.680 |
Why?
|
Genetic Testing | 6 | 2021 | 3529 | 0.650 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2019 | 40 | 0.640 |
Why?
|
Pneumothorax | 2 | 2019 | 379 | 0.630 |
Why?
|
Metalloendopeptidases | 3 | 2004 | 393 | 0.610 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2019 | 113 | 0.600 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2017 | 4352 | 0.570 |
Why?
|
Bronchial Hyperreactivity | 5 | 2009 | 302 | 0.570 |
Why?
|
Williams Syndrome | 2 | 2017 | 193 | 0.560 |
Why?
|
Gene Expression | 9 | 2020 | 7584 | 0.560 |
Why?
|
Adrenal Cortex Hormones | 9 | 2024 | 1870 | 0.550 |
Why?
|
Forced Expiratory Volume | 17 | 2024 | 1806 | 0.540 |
Why?
|
Genetic Linkage | 9 | 2014 | 2381 | 0.530 |
Why?
|
Hypersensitivity, Immediate | 3 | 2016 | 345 | 0.530 |
Why?
|
Polymorphism, Genetic | 15 | 2017 | 4283 | 0.520 |
Why?
|
Idiopathic Pulmonary Fibrosis | 4 | 2023 | 500 | 0.520 |
Why?
|
DNA Copy Number Variations | 3 | 2013 | 2012 | 0.510 |
Why?
|
Genotype | 39 | 2019 | 12951 | 0.500 |
Why?
|
alpha-N-Acetylgalactosaminidase | 1 | 2014 | 5 | 0.480 |
Why?
|
Tumor Suppressor Proteins | 2 | 2019 | 2800 | 0.480 |
Why?
|
Genetic Variation | 18 | 2018 | 6549 | 0.480 |
Why?
|
Lung | 26 | 2024 | 9979 | 0.470 |
Why?
|
Fatty Acid Desaturases | 1 | 2014 | 101 | 0.460 |
Why?
|
Membrane Proteins | 8 | 2024 | 7841 | 0.460 |
Why?
|
Genetic Markers | 12 | 2015 | 2608 | 0.450 |
Why?
|
Incidental Findings | 1 | 2019 | 693 | 0.450 |
Why?
|
Costa Rica | 13 | 2019 | 177 | 0.450 |
Why?
|
Models, Genetic | 14 | 2016 | 3441 | 0.450 |
Why?
|
Pulmonary Emphysema | 2 | 2017 | 688 | 0.450 |
Why?
|
Humans | 217 | 2024 | 757650 | 0.430 |
Why?
|
Immune System Diseases | 1 | 2015 | 258 | 0.430 |
Why?
|
Dermatitis, Atopic | 4 | 2023 | 716 | 0.430 |
Why?
|
Linkage Disequilibrium | 18 | 2017 | 1996 | 0.420 |
Why?
|
Gene Dosage | 4 | 2009 | 1218 | 0.420 |
Why?
|
NFATC Transcription Factors | 3 | 2020 | 381 | 0.410 |
Why?
|
Child | 79 | 2024 | 79787 | 0.410 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4491 | 0.410 |
Why?
|
Receptors, Adrenergic, beta-2 | 5 | 2015 | 213 | 0.410 |
Why?
|
Bronchi | 6 | 2024 | 849 | 0.400 |
Why?
|
Chromosome Mapping | 12 | 2018 | 4624 | 0.400 |
Why?
|
DNA Methylation | 8 | 2019 | 4374 | 0.400 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2012 | 82 | 0.390 |
Why?
|
Receptors, Interleukin-17 | 1 | 2011 | 80 | 0.370 |
Why?
|
Pedigree | 10 | 2021 | 4578 | 0.360 |
Why?
|
Gene Regulatory Networks | 10 | 2024 | 1740 | 0.360 |
Why?
|
Telomere | 4 | 2024 | 931 | 0.350 |
Why?
|
Asthma, Aspirin-Induced | 3 | 2019 | 200 | 0.350 |
Why?
|
Male | 125 | 2024 | 358227 | 0.350 |
Why?
|
Epistasis, Genetic | 3 | 2019 | 350 | 0.340 |
Why?
|
Family | 9 | 2020 | 3188 | 0.340 |
Why?
|
Female | 129 | 2024 | 389985 | 0.340 |
Why?
|
Churg-Strauss Syndrome | 2 | 2020 | 74 | 0.330 |
Why?
|
Respiratory Sounds | 2 | 2019 | 697 | 0.330 |
Why?
|
Vital Capacity | 5 | 2024 | 962 | 0.320 |
Why?
|
Metabolic Diseases | 1 | 2015 | 682 | 0.320 |
Why?
|
Haplotypes | 15 | 2012 | 2764 | 0.320 |
Why?
|
Karyopherins | 1 | 2009 | 130 | 0.320 |
Why?
|
Alleles | 18 | 2019 | 6894 | 0.310 |
Why?
|
Gastrectomy | 2 | 2024 | 669 | 0.300 |
Why?
|
Sex Characteristics | 4 | 2019 | 2621 | 0.300 |
Why?
|
T-Box Domain Proteins | 3 | 2019 | 468 | 0.300 |
Why?
|
Pharmacogenetics | 3 | 2012 | 675 | 0.290 |
Why?
|
Glutathione Transferase | 1 | 2009 | 564 | 0.290 |
Why?
|
Gene Frequency | 16 | 2015 | 3612 | 0.290 |
Why?
|
Sequence Deletion | 2 | 2011 | 1494 | 0.290 |
Why?
|
Epidemiologic Studies | 1 | 2011 | 670 | 0.290 |
Why?
|
Haploidy | 1 | 2007 | 133 | 0.290 |
Why?
|
Receptors, Calcitriol | 2 | 2012 | 359 | 0.280 |
Why?
|
Tobacco Smoke Pollution | 2 | 2010 | 812 | 0.280 |
Why?
|
Intermediate Filament Proteins | 1 | 2007 | 262 | 0.280 |
Why?
|
Nedocromil | 5 | 2016 | 46 | 0.280 |
Why?
|
Homozygote | 2 | 2021 | 1788 | 0.270 |
Why?
|
Child, Preschool | 29 | 2024 | 42044 | 0.270 |
Why?
|
Codon, Nonsense | 1 | 2007 | 281 | 0.270 |
Why?
|
Administration, Inhalation | 10 | 2024 | 1153 | 0.270 |
Why?
|
Prednisolone | 2 | 2020 | 326 | 0.270 |
Why?
|
Genetic Loci | 8 | 2023 | 2612 | 0.270 |
Why?
|
Microarray Analysis | 4 | 2018 | 745 | 0.260 |
Why?
|
Promoter Regions, Genetic | 11 | 2017 | 5779 | 0.260 |
Why?
|
Frameshift Mutation | 1 | 2007 | 388 | 0.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3774 | 0.260 |
Why?
|
Respiratory Function Tests | 10 | 2024 | 1680 | 0.250 |
Why?
|
Pyroglyphidae | 3 | 2012 | 88 | 0.250 |
Why?
|
Algorithms | 6 | 2017 | 13952 | 0.250 |
Why?
|
Receptors, Purinergic P2Y12 | 2 | 2018 | 115 | 0.240 |
Why?
|
Mass Screening | 1 | 2021 | 5413 | 0.240 |
Why?
|
Chemokines, CC | 1 | 2006 | 283 | 0.240 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2007 | 91 | 0.240 |
Why?
|
Genome, Human | 11 | 2019 | 4414 | 0.240 |
Why?
|
Budesonide | 4 | 2016 | 158 | 0.240 |
Why?
|
Anti-Asthmatic Agents | 5 | 2015 | 565 | 0.230 |
Why?
|
Carrier Proteins | 6 | 2019 | 4937 | 0.230 |
Why?
|
Hypertension | 10 | 2021 | 8502 | 0.230 |
Why?
|
Case-Control Studies | 26 | 2021 | 22024 | 0.220 |
Why?
|
Chromosomes, Human, Pair 17 | 4 | 2019 | 419 | 0.220 |
Why?
|
Quantitative Trait, Heritable | 6 | 2011 | 540 | 0.220 |
Why?
|
Membrane Glycoproteins | 4 | 2013 | 3705 | 0.220 |
Why?
|
Smoking | 10 | 2023 | 9036 | 0.210 |
Why?
|
Exons | 4 | 2012 | 2392 | 0.210 |
Why?
|
Computational Biology | 6 | 2020 | 3501 | 0.210 |
Why?
|
Hypertension, Pulmonary | 2 | 2024 | 1565 | 0.210 |
Why?
|
Glucocorticoids | 3 | 2020 | 2145 | 0.210 |
Why?
|
Receptors, Cell Surface | 5 | 2009 | 2825 | 0.210 |
Why?
|
Databases, Genetic | 5 | 2019 | 1737 | 0.200 |
Why?
|
Fathers | 1 | 2005 | 377 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 4 | 2016 | 1795 | 0.200 |
Why?
|
Genetic Association Studies | 8 | 2019 | 2717 | 0.200 |
Why?
|
Obesity, Morbid | 2 | 2024 | 1276 | 0.200 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2003 | 430 | 0.200 |
Why?
|
Eosinophils | 4 | 2020 | 947 | 0.200 |
Why?
|
Caveolin 1 | 2 | 2015 | 256 | 0.200 |
Why?
|
Epigenesis, Genetic | 7 | 2019 | 3754 | 0.190 |
Why?
|
Middle Aged | 52 | 2024 | 219219 | 0.190 |
Why?
|
Mucin-5B | 2 | 2023 | 147 | 0.190 |
Why?
|
CpG Islands | 5 | 2019 | 1221 | 0.190 |
Why?
|
Adolescent | 41 | 2024 | 87832 | 0.190 |
Why?
|
Adult | 55 | 2024 | 219747 | 0.190 |
Why?
|
Spinocerebellar Ataxias | 1 | 2022 | 104 | 0.180 |
Why?
|
Interleukin-12 Subunit p40 | 2 | 2019 | 57 | 0.180 |
Why?
|
Amino Acid Substitution | 1 | 2005 | 1734 | 0.180 |
Why?
|
Myosin Heavy Chains | 1 | 2022 | 402 | 0.180 |
Why?
|
Renin | 3 | 2012 | 635 | 0.180 |
Why?
|
Muscle, Smooth | 1 | 2004 | 923 | 0.180 |
Why?
|
Epithelium | 2 | 2022 | 1605 | 0.170 |
Why?
|
Enhancer Elements, Genetic | 3 | 2017 | 1356 | 0.170 |
Why?
|
Genomics | 7 | 2020 | 5788 | 0.170 |
Why?
|
ADAM Proteins | 4 | 2007 | 238 | 0.170 |
Why?
|
Neoplasm Proteins | 6 | 2024 | 3608 | 0.170 |
Why?
|
Dexamethasone | 4 | 2015 | 1927 | 0.160 |
Why?
|
Sodium Chloride, Dietary | 3 | 2012 | 293 | 0.160 |
Why?
|
Mutation | 9 | 2019 | 29928 | 0.160 |
Why?
|
Receptors, Leukotriene | 1 | 2019 | 95 | 0.160 |
Why?
|
Cohort Studies | 21 | 2020 | 41198 | 0.160 |
Why?
|
Nasal Mucosa | 2 | 2018 | 412 | 0.160 |
Why?
|
Epithelial Cells | 4 | 2024 | 3665 | 0.160 |
Why?
|
Software | 6 | 2011 | 4416 | 0.160 |
Why?
|
Hypersensitivity | 3 | 2008 | 1155 | 0.160 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2017 | 310 | 0.160 |
Why?
|
Heterozygote | 5 | 2018 | 2797 | 0.160 |
Why?
|
Obesity | 3 | 2018 | 12869 | 0.150 |
Why?
|
Sequence Analysis, RNA | 4 | 2020 | 2001 | 0.150 |
Why?
|
Smad2 Protein | 1 | 2018 | 145 | 0.150 |
Why?
|
Cilia | 1 | 2022 | 493 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 474 | 0.150 |
Why?
|
alpha 1-Antitrypsin | 1 | 2019 | 169 | 0.150 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 260 | 0.150 |
Why?
|
Sphingolipids | 1 | 2019 | 173 | 0.150 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2018 | 246 | 0.150 |
Why?
|
Bronchodilator Agents | 3 | 2016 | 505 | 0.150 |
Why?
|
Peroxiredoxins | 1 | 2018 | 51 | 0.150 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15782 | 0.150 |
Why?
|
Receptors, Immunologic | 2 | 2018 | 1411 | 0.150 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 768 | 0.150 |
Why?
|
Spirometry | 4 | 2016 | 923 | 0.140 |
Why?
|
Bayes Theorem | 3 | 2017 | 2320 | 0.140 |
Why?
|
Lung Diseases | 2 | 2018 | 1908 | 0.140 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2024 | 1014 | 0.140 |
Why?
|
Metabolism, Inborn Errors | 2 | 2018 | 285 | 0.140 |
Why?
|
Young Adult | 21 | 2020 | 58764 | 0.140 |
Why?
|
Gestational Age | 2 | 2009 | 3566 | 0.140 |
Why?
|
Nose | 1 | 2020 | 519 | 0.140 |
Why?
|
Signal Transduction | 8 | 2024 | 23342 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 591 | 0.140 |
Why?
|
Genetics, Population | 3 | 2010 | 929 | 0.130 |
Why?
|
Leukocytes | 2 | 2022 | 2025 | 0.130 |
Why?
|
Methacholine Chloride | 2 | 2014 | 220 | 0.130 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2016 | 49 | 0.130 |
Why?
|
Scopolamine Derivatives | 1 | 2015 | 24 | 0.130 |
Why?
|
beta-Defensins | 2 | 2006 | 59 | 0.130 |
Why?
|
Organoids | 1 | 2022 | 729 | 0.130 |
Why?
|
Interleukin-9 | 1 | 2016 | 61 | 0.130 |
Why?
|
Interleukin-10 | 5 | 2009 | 1174 | 0.130 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2014 | 2496 | 0.130 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2018 | 284 | 0.130 |
Why?
|
Drug Resistance | 2 | 2019 | 1593 | 0.130 |
Why?
|
alpha Catenin | 1 | 2015 | 37 | 0.130 |
Why?
|
Weight Loss | 2 | 2024 | 2671 | 0.130 |
Why?
|
RNA, Messenger | 7 | 2016 | 12761 | 0.120 |
Why?
|
Double-Blind Method | 6 | 2018 | 12260 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2895 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2017 | 327 | 0.120 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2015 | 52 | 0.120 |
Why?
|
Environmental Exposure | 5 | 2020 | 4411 | 0.120 |
Why?
|
Dinoprostone | 2 | 2016 | 598 | 0.120 |
Why?
|
Critical Illness | 2 | 2021 | 2704 | 0.120 |
Why?
|
Heart Ventricles | 2 | 2019 | 3806 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8505 | 0.120 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2015 | 107 | 0.120 |
Why?
|
Actins | 1 | 2022 | 2049 | 0.120 |
Why?
|
Semaphorins | 1 | 2015 | 96 | 0.120 |
Why?
|
Aged | 30 | 2021 | 167889 | 0.120 |
Why?
|
Cytokines | 5 | 2021 | 7339 | 0.120 |
Why?
|
Nuclear Family | 2 | 2006 | 313 | 0.120 |
Why?
|
Vitamin B 12 | 1 | 2018 | 523 | 0.120 |
Why?
|
Cholinergic Antagonists | 1 | 2015 | 164 | 0.120 |
Why?
|
Motor Vehicles | 1 | 2016 | 281 | 0.120 |
Why?
|
Air Pollution | 2 | 2020 | 2314 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 717 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 727 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2019 | 549 | 0.120 |
Why?
|
Chromosome Deletion | 2 | 2017 | 1387 | 0.120 |
Why?
|
Air Pollutants | 2 | 2020 | 2842 | 0.120 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 1098 | 0.120 |
Why?
|
Computer Simulation | 10 | 2019 | 6198 | 0.120 |
Why?
|
CLOCK Proteins | 1 | 2014 | 86 | 0.120 |
Why?
|
Autophagy | 1 | 2022 | 1322 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 782 | 0.110 |
Why?
|
Mitochondria | 1 | 2007 | 3584 | 0.110 |
Why?
|
Respiratory Hypersensitivity | 3 | 2019 | 272 | 0.110 |
Why?
|
DNA Mutational Analysis | 4 | 2012 | 4107 | 0.110 |
Why?
|
Bronchial Provocation Tests | 2 | 2011 | 216 | 0.110 |
Why?
|
Arthritis, Rheumatoid | 2 | 2021 | 3753 | 0.110 |
Why?
|
Animals | 29 | 2024 | 167777 | 0.110 |
Why?
|
Laparoscopy | 2 | 2024 | 2032 | 0.110 |
Why?
|
Neuropeptides | 1 | 2019 | 943 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2017 | 646 | 0.110 |
Why?
|
Receptors, Glucocorticoid | 1 | 2015 | 295 | 0.110 |
Why?
|
Immunity, Innate | 5 | 2019 | 3047 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1245 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2012 | 347 | 0.110 |
Why?
|
Integrin beta Chains | 1 | 2013 | 115 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1600 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 610 | 0.110 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2013 | 40 | 0.110 |
Why?
|
Untranslated Regions | 2 | 2012 | 29 | 0.110 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1698 | 0.110 |
Why?
|
Insulin Resistance | 3 | 2011 | 3941 | 0.110 |
Why?
|
Receptors, Cytokine | 1 | 2014 | 258 | 0.110 |
Why?
|
Molecular Sequence Annotation | 2 | 2013 | 524 | 0.110 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2619 | 0.100 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2012 | 30 | 0.100 |
Why?
|
Sputum | 1 | 2015 | 501 | 0.100 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2015 | 446 | 0.100 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2013 | 174 | 0.100 |
Why?
|
Epigenomics | 1 | 2018 | 936 | 0.100 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2013 | 158 | 0.100 |
Why?
|
Mineralocorticoids | 1 | 2012 | 37 | 0.100 |
Why?
|
Mucin-1 | 1 | 2017 | 539 | 0.100 |
Why?
|
HLA-DQ Antigens | 1 | 2012 | 211 | 0.100 |
Why?
|
RNA | 2 | 2020 | 2716 | 0.100 |
Why?
|
Follow-Up Studies | 8 | 2022 | 39018 | 0.100 |
Why?
|
Mandibulofacial Dysostosis | 1 | 2011 | 36 | 0.100 |
Why?
|
Fibroblasts | 4 | 2018 | 4087 | 0.100 |
Why?
|
Principal Component Analysis | 2 | 2015 | 940 | 0.100 |
Why?
|
Bariatric Surgery | 1 | 2022 | 986 | 0.100 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2012 | 110 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.100 |
Why?
|
Craniofacial Dysostosis | 1 | 2011 | 74 | 0.100 |
Why?
|
Sweat | 1 | 2011 | 56 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1004 | 0.100 |
Why?
|
DNA | 4 | 2012 | 7199 | 0.100 |
Why?
|
Micrognathism | 1 | 2011 | 63 | 0.100 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2008 | 607 | 0.100 |
Why?
|
Toll-Like Receptor 9 | 2 | 2011 | 234 | 0.100 |
Why?
|
Serpins | 1 | 2013 | 247 | 0.100 |
Why?
|
Autoimmune Diseases | 2 | 2017 | 2243 | 0.100 |
Why?
|
Macrophages, Alveolar | 1 | 2014 | 409 | 0.090 |
Why?
|
Serpin E2 | 1 | 2011 | 48 | 0.090 |
Why?
|
Kallikreins | 1 | 2012 | 218 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2012 | 163 | 0.090 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14478 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2506 | 0.090 |
Why?
|
beta Catenin | 1 | 2016 | 1043 | 0.090 |
Why?
|
Vitamins | 1 | 2019 | 1632 | 0.090 |
Why?
|
Calcitriol | 1 | 2012 | 297 | 0.090 |
Why?
|
Immunity | 1 | 2017 | 997 | 0.090 |
Why?
|
Body Mass Index | 5 | 2021 | 12870 | 0.090 |
Why?
|
Limb Deformities, Congenital | 1 | 2011 | 136 | 0.090 |
Why?
|
Pericytes | 2 | 2024 | 293 | 0.090 |
Why?
|
Logistic Models | 8 | 2017 | 13222 | 0.090 |
Why?
|
Puerto Rico | 3 | 2017 | 373 | 0.090 |
Why?
|
Normal Distribution | 1 | 2011 | 272 | 0.090 |
Why?
|
Drug Hypersensitivity | 1 | 2019 | 915 | 0.090 |
Why?
|
Angiotensinogen | 1 | 2011 | 161 | 0.090 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2018 | 633 | 0.090 |
Why?
|
Base Sequence | 6 | 2018 | 12437 | 0.090 |
Why?
|
Nasal Polyps | 1 | 2016 | 395 | 0.090 |
Why?
|
MicroRNAs | 2 | 2017 | 3782 | 0.090 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2009 | 44 | 0.090 |
Why?
|
Cell Line | 7 | 2024 | 15594 | 0.090 |
Why?
|
DNA-Binding Proteins | 7 | 2019 | 9574 | 0.090 |
Why?
|
Hydrocortisone | 2 | 2015 | 1802 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2011 | 788 | 0.090 |
Why?
|
Lung Transplantation | 2 | 2016 | 1305 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2020 | 13267 | 0.090 |
Why?
|
Models, Statistical | 5 | 2020 | 5068 | 0.090 |
Why?
|
Egg Proteins | 1 | 2009 | 57 | 0.090 |
Why?
|
Genetic Complementation Test | 1 | 2010 | 555 | 0.080 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2011 | 175 | 0.080 |
Why?
|
Mice | 15 | 2024 | 81107 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2269 | 0.080 |
Why?
|
Endothelial Cells | 4 | 2024 | 3533 | 0.080 |
Why?
|
Allergens | 3 | 2012 | 1402 | 0.080 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 41 | 0.080 |
Why?
|
Histone Demethylases | 1 | 2012 | 319 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2020 | 20999 | 0.080 |
Why?
|
Respiration | 1 | 2016 | 1654 | 0.080 |
Why?
|
Life Style | 1 | 2021 | 3886 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5722 | 0.080 |
Why?
|
Vestibular Diseases | 1 | 2011 | 229 | 0.080 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 76 | 0.080 |
Why?
|
Particulate Matter | 2 | 2020 | 2556 | 0.080 |
Why?
|
Eosinophilia | 2 | 2018 | 559 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2870 | 0.080 |
Why?
|
Atrial Natriuretic Factor | 1 | 2010 | 350 | 0.080 |
Why?
|
Cell Nucleus | 2 | 2015 | 2905 | 0.080 |
Why?
|
Integrin beta3 | 1 | 2009 | 120 | 0.080 |
Why?
|
Family Health | 2 | 2018 | 1256 | 0.080 |
Why?
|
Genome | 1 | 2016 | 1739 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2019 | 2108 | 0.080 |
Why?
|
Pneumonia | 2 | 2024 | 2127 | 0.080 |
Why?
|
Leukocyte Count | 3 | 2022 | 1595 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4540 | 0.080 |
Why?
|
Transforming Growth Factor beta | 3 | 2006 | 1957 | 0.080 |
Why?
|
Antigens, Dermatophagoides | 1 | 2008 | 97 | 0.080 |
Why?
|
Gene Order | 2 | 2007 | 169 | 0.070 |
Why?
|
Indians, Central American | 1 | 2007 | 19 | 0.070 |
Why?
|
Cockroaches | 1 | 2008 | 97 | 0.070 |
Why?
|
Endotoxins | 2 | 2014 | 521 | 0.070 |
Why?
|
Hematologic Diseases | 1 | 2011 | 496 | 0.070 |
Why?
|
Aspirin | 1 | 2019 | 3131 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2013 | 6069 | 0.070 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
Prospective Studies | 9 | 2024 | 54108 | 0.070 |
Why?
|
Systems Biology | 1 | 2011 | 482 | 0.070 |
Why?
|
Ethanolamines | 2 | 2019 | 153 | 0.070 |
Why?
|
PPAR gamma | 1 | 2010 | 482 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2004 | 6231 | 0.070 |
Why?
|
Tissue Donors | 1 | 2016 | 2311 | 0.070 |
Why?
|
Scavenger Receptors, Class A | 1 | 2006 | 52 | 0.070 |
Why?
|
Sex Factors | 6 | 2016 | 10497 | 0.070 |
Why?
|
Dyspnea | 3 | 2021 | 1344 | 0.070 |
Why?
|
Transcription Factors | 7 | 2019 | 12092 | 0.070 |
Why?
|
Ischemia | 1 | 2015 | 1863 | 0.070 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2006 | 127 | 0.070 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2006 | 94 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2012 | 747 | 0.070 |
Why?
|
Neutrophils | 2 | 2022 | 3765 | 0.070 |
Why?
|
Myocardium | 1 | 2019 | 4690 | 0.070 |
Why?
|
Treatment Outcome | 9 | 2024 | 64242 | 0.070 |
Why?
|
Chemokine CCL11 | 1 | 2006 | 128 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5481 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2015 | 3602 | 0.070 |
Why?
|
Incidence | 5 | 2021 | 21217 | 0.070 |
Why?
|
Tropoelastin | 1 | 2005 | 28 | 0.060 |
Why?
|
Genetic Diseases, Inborn | 1 | 2010 | 601 | 0.060 |
Why?
|
Risk Factors | 14 | 2023 | 73716 | 0.060 |
Why?
|
Wnt Proteins | 1 | 2009 | 719 | 0.060 |
Why?
|
Odds Ratio | 3 | 2014 | 9624 | 0.060 |
Why?
|
Environment | 1 | 2011 | 1118 | 0.060 |
Why?
|
Maternal Exposure | 1 | 2012 | 1045 | 0.060 |
Why?
|
Osteoblasts | 1 | 2011 | 1142 | 0.060 |
Why?
|
Skin Tests | 1 | 2007 | 637 | 0.060 |
Why?
|
Iodide Peroxidase | 1 | 2007 | 294 | 0.060 |
Why?
|
Aged, 80 and over | 11 | 2019 | 58559 | 0.060 |
Why?
|
Interleukin-13 | 1 | 2007 | 372 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2022 | 11470 | 0.060 |
Why?
|
Microsatellite Repeats | 2 | 2006 | 785 | 0.060 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12047 | 0.060 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2006 | 452 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2910 | 0.060 |
Why?
|
Time Factors | 5 | 2021 | 39815 | 0.060 |
Why?
|
Pancreas | 1 | 2011 | 1676 | 0.060 |
Why?
|
Fungi | 1 | 2007 | 338 | 0.060 |
Why?
|
Inhalation Exposure | 1 | 2007 | 429 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15209 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3167 | 0.060 |
Why?
|
Albuterol | 2 | 2015 | 212 | 0.060 |
Why?
|
Quebec | 1 | 2004 | 140 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 1895 | 0.060 |
Why?
|
Acetylation | 2 | 2018 | 1060 | 0.060 |
Why?
|
Estrogens | 1 | 2011 | 1521 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1414 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2018 | 18941 | 0.060 |
Why?
|
Ammonia-Lyases | 1 | 2003 | 6 | 0.060 |
Why?
|
Hydroxymethyl and Formyl Transferases | 1 | 2003 | 18 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4567 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2017 | 3560 | 0.060 |
Why?
|
Fibroblast Growth Factors | 2 | 2023 | 867 | 0.060 |
Why?
|
T-Lymphocytes | 3 | 2020 | 10172 | 0.060 |
Why?
|
Drug Design | 1 | 2009 | 1049 | 0.060 |
Why?
|
Body Height | 2 | 2013 | 1567 | 0.060 |
Why?
|
Medical Oncology | 1 | 1995 | 2308 | 0.050 |
Why?
|
Multicenter Studies as Topic | 2 | 2005 | 1702 | 0.050 |
Why?
|
ROC Curve | 2 | 2024 | 3562 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2020 | 1826 | 0.050 |
Why?
|
Canada | 3 | 2012 | 2108 | 0.050 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2004 | 385 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2014 | 2567 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2461 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20039 | 0.050 |
Why?
|
North America | 3 | 2012 | 1273 | 0.050 |
Why?
|
K562 Cells | 1 | 2024 | 639 | 0.050 |
Why?
|
Hypertrophy | 1 | 2004 | 555 | 0.050 |
Why?
|
Cystic Fibrosis | 1 | 2011 | 1274 | 0.050 |
Why?
|
Infant | 7 | 2024 | 36043 | 0.050 |
Why?
|
Cloning, Molecular | 2 | 2007 | 4169 | 0.050 |
Why?
|
Insulin | 3 | 2011 | 6578 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4738 | 0.050 |
Why?
|
Interleukin-12 | 1 | 2004 | 583 | 0.050 |
Why?
|
Eczema | 1 | 2004 | 245 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2011 | 3208 | 0.050 |
Why?
|
Pregnancy | 5 | 2019 | 29720 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2015 | 435 | 0.050 |
Why?
|
Dust | 1 | 2004 | 486 | 0.050 |
Why?
|
Medical History Taking | 1 | 2005 | 772 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10135 | 0.050 |
Why?
|
Exercise Tolerance | 1 | 2006 | 830 | 0.040 |
Why?
|
Hemodynamics | 1 | 2011 | 4156 | 0.040 |
Why?
|
Lymphocytosis | 1 | 2021 | 119 | 0.040 |
Why?
|
Up-Regulation | 3 | 2017 | 4113 | 0.040 |
Why?
|
Anxiety | 1 | 2015 | 4533 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2014 | 3732 | 0.040 |
Why?
|
Age of Onset | 3 | 2015 | 3296 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2015 | 25931 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2005 | 1091 | 0.040 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.040 |
Why?
|
Prognosis | 6 | 2024 | 29493 | 0.040 |
Why?
|
Leukocytosis | 1 | 2021 | 251 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2021 | 225 | 0.040 |
Why?
|
Linear Models | 3 | 2015 | 5857 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2014 | 5243 | 0.040 |
Why?
|
Blood Pressure | 2 | 2012 | 8452 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18123 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2016 | 10750 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2015 | 4456 | 0.040 |
Why?
|
Clinical Competence | 1 | 1995 | 4760 | 0.040 |
Why?
|
Cattle | 1 | 2005 | 3845 | 0.040 |
Why?
|
Risk | 3 | 2017 | 9590 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7503 | 0.040 |
Why?
|
Group IV Phospholipases A2 | 1 | 2019 | 58 | 0.040 |
Why?
|
Lymphocytes | 2 | 2019 | 2611 | 0.040 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2019 | 90 | 0.040 |
Why?
|
Vitamin D | 2 | 2011 | 3283 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2000 | 266 | 0.040 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2024 | 364 | 0.040 |
Why?
|
Interleukin-5 | 1 | 2020 | 269 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2002 | 590 | 0.040 |
Why?
|
Probability | 1 | 2004 | 2461 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2002 | 577 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2005 | 3090 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 188 | 0.040 |
Why?
|
Disease Progression | 3 | 2023 | 13464 | 0.040 |
Why?
|
Down-Regulation | 2 | 2015 | 2903 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3480 | 0.040 |
Why?
|
Mucus | 1 | 2019 | 342 | 0.040 |
Why?
|
Aldosterone | 2 | 2012 | 866 | 0.040 |
Why?
|
Meta-Analysis as Topic | 2 | 2012 | 1373 | 0.040 |
Why?
|
Syndrome | 1 | 2004 | 3261 | 0.040 |
Why?
|
Sphingosine | 1 | 2019 | 308 | 0.040 |
Why?
|
Iceland | 1 | 2017 | 184 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 2211 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2021 | 920 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7590 | 0.040 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2017 | 104 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2015 | 2673 | 0.040 |
Why?
|
Lysophospholipids | 1 | 2019 | 338 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2847 | 0.040 |
Why?
|
Reference Values | 1 | 2004 | 4918 | 0.040 |
Why?
|
Inflammasomes | 1 | 2022 | 527 | 0.030 |
Why?
|
Histone Code | 1 | 2017 | 155 | 0.030 |
Why?
|
Postoperative Period | 1 | 2022 | 1806 | 0.030 |
Why?
|
Histones | 2 | 2018 | 2577 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 1995 | 5272 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2019 | 26173 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2009 | 17617 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2019 | 14354 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2021 | 79982 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2022 | 20499 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2017 | 285 | 0.030 |
Why?
|
Birth Weight | 1 | 2004 | 2096 | 0.030 |
Why?
|
Azacitidine | 1 | 2018 | 334 | 0.030 |
Why?
|
Virginia | 1 | 2016 | 117 | 0.030 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2015 | 74 | 0.030 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 69 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2038 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2018 | 411 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6758 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 550 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 279 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4406 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 715 | 0.030 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 29 | 0.030 |
Why?
|
Infant, Premature | 1 | 2004 | 2093 | 0.030 |
Why?
|
Rhode Island | 1 | 2015 | 350 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 567 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 396 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2015 | 193 | 0.030 |
Why?
|
Remission Induction | 1 | 2020 | 2391 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 869 | 0.030 |
Why?
|
Sheep | 1 | 2016 | 1439 | 0.030 |
Why?
|
Lysine | 1 | 2018 | 998 | 0.030 |
Why?
|
Risk Assessment | 3 | 2024 | 23819 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 913 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 522 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13447 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18328 | 0.030 |
Why?
|
Recurrence | 2 | 2020 | 8426 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14638 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 437 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2014 | 362 | 0.030 |
Why?
|
Immunomodulation | 1 | 2017 | 545 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2019 | 909 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2016 | 10416 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1611 | 0.030 |
Why?
|
Carbon | 1 | 2016 | 667 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2687 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 2012 | 231 | 0.030 |
Why?
|
Granulocytes | 1 | 2014 | 550 | 0.030 |
Why?
|
Proteins | 2 | 2019 | 6026 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1722 | 0.030 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 28 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2048 | 0.030 |
Why?
|
Potassium, Dietary | 1 | 2012 | 103 | 0.030 |
Why?
|
Leukotriene E4 | 1 | 2012 | 75 | 0.020 |
Why?
|
Prenatal Care | 1 | 2019 | 1129 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2212 | 0.020 |
Why?
|
United States | 6 | 2021 | 71907 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9519 | 0.020 |
Why?
|
Pulmonary Eosinophilia | 1 | 2012 | 78 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 294 | 0.020 |
Why?
|
Heredity | 1 | 2011 | 148 | 0.020 |
Why?
|
Cities | 1 | 2014 | 541 | 0.020 |
Why?
|
Nurses | 1 | 2021 | 2467 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4190 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 617 | 0.020 |
Why?
|
Caribbean Region | 1 | 2011 | 191 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1753 | 0.020 |
Why?
|
Random Allocation | 1 | 1995 | 2387 | 0.020 |
Why?
|
Functional Residual Capacity | 1 | 2010 | 69 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2012 | 1154 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2011 | 377 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 772 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2004 | 1693 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2011 | 504 | 0.020 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 174 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3668 | 0.020 |
Why?
|
Barbados | 1 | 2009 | 52 | 0.020 |
Why?
|
Telomerase | 1 | 2015 | 745 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2019 | 2187 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 459 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5782 | 0.020 |
Why?
|
Steroid Hydroxylases | 1 | 2009 | 96 | 0.020 |
Why?
|
Wound Healing | 1 | 2000 | 2781 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2013 | 441 | 0.020 |
Why?
|
Rats | 3 | 2012 | 23681 | 0.020 |
Why?
|
Aortic Valve | 1 | 2019 | 1950 | 0.020 |
Why?
|
Transition Temperature | 1 | 2008 | 33 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3521 | 0.020 |
Why?
|
Sweden | 1 | 2012 | 1376 | 0.020 |
Why?
|
Chlorides | 1 | 2011 | 663 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2011 | 342 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 857 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15641 | 0.020 |
Why?
|
Antigens, Ly | 1 | 2010 | 292 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 829 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 2012 | 425 | 0.020 |
Why?
|
Cell Movement | 1 | 2000 | 5201 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2012 | 814 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2016 | 1365 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1609 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 7926 | 0.020 |
Why?
|
Sex Ratio | 1 | 2008 | 107 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2004 | 0.020 |
Why?
|
Lung Diseases, Obstructive | 1 | 2008 | 308 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2010 | 748 | 0.020 |
Why?
|
Genetics, Medical | 1 | 2010 | 336 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22008 | 0.020 |
Why?
|
Health | 1 | 2010 | 398 | 0.020 |
Why?
|
Pseudomonas Infections | 1 | 2011 | 621 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2012 | 4710 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3709 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2696 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3709 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 758 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2634 | 0.020 |
Why?
|
Goblet Cells | 1 | 2010 | 299 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1153 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3887 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2816 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 328 | 0.020 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2006 | 43 | 0.020 |
Why?
|
NF-kappa B | 1 | 2015 | 2472 | 0.020 |
Why?
|
Edema | 1 | 2010 | 769 | 0.020 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 1 | 2006 | 42 | 0.020 |
Why?
|
Emphysema | 1 | 2008 | 240 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 1955 | 0.020 |
Why?
|
Rhinitis | 1 | 2014 | 746 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1342 | 0.020 |
Why?
|
Australia | 1 | 2009 | 1235 | 0.020 |
Why?
|
Face | 1 | 2011 | 1017 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6469 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6293 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2009 | 1527 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2006 | 122 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12400 | 0.020 |
Why?
|
Toll-Like Receptor 6 | 1 | 2004 | 29 | 0.020 |
Why?
|
Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.020 |
Why?
|
Fasting | 1 | 2011 | 1599 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7226 | 0.010 |
Why?
|
Metabolomics | 1 | 2014 | 1629 | 0.010 |
Why?
|
Placebos | 1 | 2009 | 1661 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2007 | 427 | 0.010 |
Why?
|
Exercise | 1 | 2021 | 5788 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5031 | 0.010 |
Why?
|
Histidine | 1 | 2004 | 308 | 0.010 |
Why?
|
Glutamate Formimidoyltransferase | 1 | 2003 | 3 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 195 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3603 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3432 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2357 | 0.010 |
Why?
|
YY1 Transcription Factor | 1 | 2003 | 59 | 0.010 |
Why?
|
Research Design | 2 | 2010 | 6151 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7982 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4426 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4235 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9297 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2006 | 1844 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4158 | 0.010 |
Why?
|
Inheritance Patterns | 1 | 2004 | 340 | 0.010 |
Why?
|
HLA Antigens | 1 | 2007 | 1368 | 0.010 |
Why?
|
Glutamine | 1 | 2004 | 575 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 2004 | 514 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 635 | 0.010 |
Why?
|
Skin Diseases | 1 | 2010 | 1088 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 1995 | 3864 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2004 | 1991 | 0.010 |
Why?
|
Survival Rate | 1 | 1995 | 12685 | 0.010 |
Why?
|
Introns | 1 | 2004 | 978 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2007 | 1355 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3302 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16891 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6457 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 665 | 0.010 |
Why?
|
Sepsis | 1 | 2014 | 2583 | 0.010 |
Why?
|
Th1 Cells | 1 | 2004 | 1031 | 0.010 |
Why?
|
Th2 Cells | 1 | 2004 | 1047 | 0.010 |
Why?
|
Dogs | 1 | 2004 | 3838 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6336 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8815 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 1170 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6349 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7013 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10718 | 0.010 |
Why?
|
Diet | 1 | 2012 | 8003 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2003 | 2565 | 0.010 |
Why?
|
Swine | 1 | 2003 | 5892 | 0.010 |
Why?
|